Leslie Norwalk, a former Magellan Health board member, is joining Centene’s board of directors, the payer announced Jan. 11.
Category: Payer Issues
UnitedHealthcare settles class-action underpayment suit for $10M
The U.S. District Court for the Eastern District of New York approved a $10 million final settlement for a class-action lawsuit targeting UnitedHealthcare and its tiered reimbursement policy.
CMS unveils preliminary Aduhelm coverage decision
CMS intends for Medicare to cover Aduhelm, Biogen’s Alzheimer’s disease treatment, for patients taking part in clinical trials, the agency announced Jan. 11.
Anthem files to overturn order temporarily extending Northside network contract
Anthem filed a pair of motions Jan. 7 that aim to end a temporary court order requiring it keep Atlanta-based Northside Hospital System in its network.
Mental health, obesity prevention benefits added to ACA plans for women, children
The Health Resources and Services Administration is expanding ACA preventive care and screening coverage for women and children, HHS announced Jan. 11.
CVS Caremark secures $3.4B North Carolina pharmacy benefit management contract
North Carolina awarded CVS Caremark, CVS Health’s pharmacy benefit manager, a $3.4 billion contract to serve the state’s 727,000 public employees.
Payer advocates react to Biden at-home COVID-19 test coverage rule
Payer representatives are both praising President Joe Biden’s sweeping new at-home COVID-19 test coverage policy and raising concerns over its implementation and impacts.
Payers must cover at-home COVID-19 tests starting Jan. 15
Private insurers must cover the cost of up to eight at-home COVID-19 tests per month effective Jan. 15, according to an HHS news release.
2022 open enrollment period pacing 21% higher enrollment over previous year
HHS announced 13.8 million people are enrolled in an ACA plan, expanding on an enrollment record set in December, according to a Jan. 10 news release.
HHS calls for review of Medicare Part B premium hike following Aduhelm price cut
HHS Secretary Xavier Becerra is ordering CMS to review its 2022 Medicare Part B premiums following the announcement that Biogen would be slashing the price of its Alzheimer’s disease drug in half, according to a Jan. 10 news release.
